Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 23 | 2023 | 349 | 4.860 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 10 | 2022 | 35 | 1.970 |
Why?
|
| Meningoencephalitis | 1 | 2021 | 24 | 0.790 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2021 | 25 | 0.790 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2021 | 33 | 0.790 |
Why?
|
| JC Virus | 1 | 2021 | 43 | 0.780 |
Why?
|
| Interferon-beta | 6 | 2011 | 102 | 0.710 |
Why?
|
| Immunosuppressive Agents | 14 | 2023 | 1375 | 0.670 |
Why?
|
| Ganglioglioma | 1 | 2016 | 41 | 0.560 |
Why?
|
| Fingolimod Hydrochloride | 4 | 2023 | 45 | 0.510 |
Why?
|
| Brain Diseases | 2 | 2019 | 403 | 0.390 |
Why?
|
| Osteopontin | 1 | 2010 | 148 | 0.360 |
Why?
|
| Glioblastoma | 1 | 2021 | 1797 | 0.360 |
Why?
|
| Pneumocephalus | 1 | 2008 | 7 | 0.340 |
Why?
|
| Injections, Epidural | 1 | 2008 | 23 | 0.340 |
Why?
|
| Lateral Ventricles | 1 | 2008 | 26 | 0.340 |
Why?
|
| Interleukin-17 | 1 | 2010 | 250 | 0.330 |
Why?
|
| Dura Mater | 1 | 2008 | 73 | 0.320 |
Why?
|
| Headache | 1 | 2008 | 163 | 0.310 |
Why?
|
| Dimethyl Fumarate | 3 | 2023 | 10 | 0.310 |
Why?
|
| Sarcoidosis | 1 | 2008 | 112 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2021 | 7702 | 0.240 |
Why?
|
| Urinary Retention | 1 | 2021 | 21 | 0.200 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2021 | 20 | 0.200 |
Why?
|
| Alemtuzumab | 2 | 2020 | 198 | 0.200 |
Why?
|
| Herpes Simplex | 1 | 2022 | 95 | 0.190 |
Why?
|
| Cost of Illness | 2 | 2020 | 498 | 0.190 |
Why?
|
| Brain | 6 | 2021 | 4113 | 0.190 |
Why?
|
| Methotrexate | 3 | 2009 | 999 | 0.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2021 | 6550 | 0.180 |
Why?
|
| Methylprednisolone | 3 | 2009 | 193 | 0.170 |
Why?
|
| Prescription Drugs | 1 | 2020 | 64 | 0.170 |
Why?
|
| Adjuvants, Immunologic | 3 | 2009 | 657 | 0.170 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 4849 | 0.170 |
Why?
|
| Health Expenditures | 2 | 2020 | 211 | 0.170 |
Why?
|
| Humans | 36 | 2023 | 261506 | 0.160 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 643 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 945 | 0.140 |
Why?
|
| Adult | 20 | 2023 | 77950 | 0.130 |
Why?
|
| Antigens, CD34 | 1 | 2016 | 593 | 0.120 |
Why?
|
| Spinal Cord | 4 | 2021 | 690 | 0.120 |
Why?
|
| Dendritic Cells | 2 | 2011 | 1085 | 0.100 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2011 | 19 | 0.100 |
Why?
|
| Electroencephalography | 1 | 2016 | 898 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 1945 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2005 | 3341 | 0.100 |
Why?
|
| Middle Aged | 14 | 2022 | 86204 | 0.100 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2011 | 67 | 0.100 |
Why?
|
| Female | 19 | 2022 | 141928 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2009 | 461 | 0.100 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 1249 | 0.090 |
Why?
|
| Male | 16 | 2022 | 123000 | 0.090 |
Why?
|
| Treatment Outcome | 7 | 2021 | 32848 | 0.090 |
Why?
|
| Young Adult | 3 | 2022 | 21445 | 0.080 |
Why?
|
| Glatiramer Acetate | 3 | 2022 | 13 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 1491 | 0.080 |
Why?
|
| Atrophy | 3 | 2021 | 261 | 0.080 |
Why?
|
| Neuromyelitis Optica | 1 | 2008 | 26 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2011 | 2074 | 0.080 |
Why?
|
| Lymphocyte Activation | 2 | 2011 | 1688 | 0.080 |
Why?
|
| Bupivacaine | 1 | 2008 | 68 | 0.080 |
Why?
|
| Quality of Life | 1 | 2022 | 4532 | 0.080 |
Why?
|
| Linear Models | 2 | 2022 | 1085 | 0.080 |
Why?
|
| Low Back Pain | 1 | 2008 | 83 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2011 | 649 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 673 | 0.080 |
Why?
|
| Encephalitis, Viral | 1 | 2007 | 30 | 0.070 |
Why?
|
| Interferon beta-1a | 4 | 2009 | 21 | 0.070 |
Why?
|
| Roseolovirus Infections | 1 | 2007 | 39 | 0.070 |
Why?
|
| Steroids | 1 | 2008 | 356 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 4367 | 0.070 |
Why?
|
| Herpesvirus 6, Human | 1 | 2007 | 81 | 0.070 |
Why?
|
| Disability Evaluation | 3 | 2017 | 249 | 0.070 |
Why?
|
| Antibodies, Neoplasm | 1 | 2007 | 259 | 0.070 |
Why?
|
| Prednisone | 1 | 2008 | 984 | 0.070 |
Why?
|
| Meningioma | 1 | 2008 | 289 | 0.070 |
Why?
|
| Recurrence | 3 | 2022 | 4758 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2011 | 2450 | 0.070 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2004 | 10 | 0.060 |
Why?
|
| Financing, Personal | 1 | 2004 | 19 | 0.060 |
Why?
|
| Retrospective Studies | 6 | 2023 | 37905 | 0.060 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2004 | 33 | 0.060 |
Why?
|
| Meningeal Neoplasms | 1 | 2008 | 441 | 0.060 |
Why?
|
| Myelin Basic Protein | 1 | 2004 | 85 | 0.060 |
Why?
|
| Transplantation, Autologous | 3 | 2017 | 1914 | 0.060 |
Why?
|
| Logistic Models | 2 | 2022 | 3441 | 0.060 |
Why?
|
| Crotonates | 1 | 2023 | 5 | 0.060 |
Why?
|
| Drugs, Investigational | 1 | 2005 | 135 | 0.060 |
Why?
|
| Biopsy | 2 | 2008 | 3443 | 0.060 |
Why?
|
| Acute Disease | 1 | 2008 | 2422 | 0.060 |
Why?
|
| Autoantigens | 1 | 2004 | 234 | 0.050 |
Why?
|
| Epitopes | 1 | 2005 | 685 | 0.050 |
Why?
|
| Adolescent | 7 | 2022 | 31252 | 0.050 |
Why?
|
| Paraparesis | 1 | 2021 | 17 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2004 | 362 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2002 | 250 | 0.050 |
Why?
|
| Genetic Markers | 1 | 2004 | 974 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2005 | 576 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2005 | 561 | 0.050 |
Why?
|
| Constipation | 1 | 2021 | 177 | 0.050 |
Why?
|
| Monocytes | 1 | 2004 | 788 | 0.050 |
Why?
|
| Injections | 1 | 2021 | 285 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 4314 | 0.050 |
Why?
|
| Peptides | 2 | 2004 | 1479 | 0.050 |
Why?
|
| Models, Economic | 1 | 2020 | 101 | 0.050 |
Why?
|
| Office Visits | 1 | 2020 | 97 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 552 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 254 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 4744 | 0.040 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 112 | 0.040 |
Why?
|
| Lactation | 1 | 2020 | 210 | 0.040 |
Why?
|
| United States | 3 | 2020 | 15433 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2020 | 430 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2023 | 492 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 9244 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 341 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2021 | 1544 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2004 | 1360 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2009 | 313 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 2316 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 2 | 2009 | 482 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 14889 | 0.030 |
Why?
|
| Aged | 5 | 2021 | 70117 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1819 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2011 | 5637 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 3719 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2004 | 3869 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 10001 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2009 | 2315 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 7551 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2020 | 929 | 0.030 |
Why?
|
| Clonal Anergy | 1 | 2011 | 13 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 5159 | 0.030 |
Why?
|
| Natalizumab | 1 | 2011 | 4 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 1303 | 0.020 |
Why?
|
| Hospitalization | 1 | 2020 | 2083 | 0.020 |
Why?
|
| Patient Selection | 2 | 2009 | 2055 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 5687 | 0.020 |
Why?
|
| Disease Progression | 2 | 2015 | 6682 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 29902 | 0.020 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2008 | 26 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2004 | 1538 | 0.020 |
Why?
|
| Algorithms | 1 | 2019 | 3890 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2011 | 3251 | 0.020 |
Why?
|
| CTLA-4 Antigen | 1 | 2011 | 657 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 3639 | 0.020 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2007 | 26 | 0.020 |
Why?
|
| Autopsy | 1 | 2007 | 173 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7573 | 0.020 |
Why?
|
| Chad | 1 | 2004 | 1 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2008 | 629 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2007 | 694 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 1021 | 0.020 |
Why?
|
| Axons | 1 | 2007 | 403 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2007 | 1391 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2004 | 87 | 0.020 |
Why?
|
| Income | 1 | 2004 | 222 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2004 | 173 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 461 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8865 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2004 | 294 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2004 | 486 | 0.010 |
Why?
|
| Data Collection | 1 | 2004 | 620 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 5710 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 709 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2004 | 478 | 0.010 |
Why?
|
| Poverty | 1 | 2004 | 471 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 3203 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2007 | 2843 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 6942 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2004 | 1681 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 4971 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2004 | 1144 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 2489 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2007 | 2238 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 2508 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 904 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 2927 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2002 | 1146 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2007 | 1870 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2004 | 4078 | 0.010 |
Why?
|
| Cytokines | 1 | 2002 | 2809 | 0.010 |
Why?
|
| Infant | 1 | 2008 | 13310 | 0.010 |
Why?
|
| Animals | 2 | 2011 | 59536 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 16273 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 34495 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 17523 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 12926 | 0.010 |
Why?
|
| Child | 1 | 2008 | 29154 | 0.000 |
Why?
|